US NIH (National Institutes of Health) in first stem cell deal:
This article was originally published in Clinica
The National Institutes of Health (NIH) has signed the first international agreement involving the distribution of human stem cells. ES Cell International of Melbourne, Australia, has agreed to make its six existing stem cell lines available to NIH and non-profit institutions for a handling fee and will retain all commercial rights. NIH will retain its ownership to any new intellectual property that might arise. The stem cells meet the government's ethical criteria necessary in order to be used in federally-funded laboratories.
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.